SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097496
Filing Date
2024-11-13
Accepted
2024-11-13 16:30:28
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0219124-10q_pasithea.htm   iXBRL 10-Q 712824
2 CERTIFICATION ea021912401ex31-1_pasi.htm EX-31.1 10222
3 CERTIFICATION ea021912401ex31-2_pasi.htm EX-31.2 10519
4 CERTIFICATION ea021912401ex32-1_pasi.htm EX-32.1 4328
5 CERTIFICATION ea021912401ex32-2_pasi.htm EX-32.2 4556
  Complete submission text file 0001213900-24-097496.txt   4987280

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ktta-20240930.xsd EX-101.SCH 38886
7 XBRL CALCULATION FILE ktta-20240930_cal.xml EX-101.CAL 37281
8 XBRL DEFINITION FILE ktta-20240930_def.xml EX-101.DEF 251000
9 XBRL LABEL FILE ktta-20240930_lab.xml EX-101.LAB 422794
10 XBRL PRESENTATION FILE ktta-20240930_pre.xml EX-101.PRE 247182
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0219124-10q_pasithea_htm.xml XML 573285
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40804 | Film No.: 241454882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)